Copyright Reports & Markets. All rights reserved.

Global Oral Solid Dosage Contract Manufacturing Market Size, Status and Forecast 2021-2027

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Oral Solid Dosage Contract Manufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Tablets
    • 1.2.3 Capsules
    • 1.2.4 Powders & Granules
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Oral Solid Dosage Contract Manufacturing Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Specialty/Midsize
    • 1.3.3 Generics
    • 1.3.4 Big Pharma
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Oral Solid Dosage Contract Manufacturing Market Perspective (2016-2027)
  • 2.2 Oral Solid Dosage Contract Manufacturing Growth Trends by Regions
    • 2.2.1 Oral Solid Dosage Contract Manufacturing Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Oral Solid Dosage Contract Manufacturing Historic Market Share by Regions (2016-2021)
    • 2.2.3 Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Regions (2022-2027)
  • 2.3 Oral Solid Dosage Contract Manufacturing Industry Dynamic
    • 2.3.1 Oral Solid Dosage Contract Manufacturing Market Trends
    • 2.3.2 Oral Solid Dosage Contract Manufacturing Market Drivers
    • 2.3.3 Oral Solid Dosage Contract Manufacturing Market Challenges
    • 2.3.4 Oral Solid Dosage Contract Manufacturing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Oral Solid Dosage Contract Manufacturing Players by Revenue
    • 3.1.1 Global Top Oral Solid Dosage Contract Manufacturing Players by Revenue (2016-2021)
    • 3.1.2 Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Players (2016-2021)
  • 3.2 Global Oral Solid Dosage Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Oral Solid Dosage Contract Manufacturing Revenue
  • 3.4 Global Oral Solid Dosage Contract Manufacturing Market Concentration Ratio
    • 3.4.1 Global Oral Solid Dosage Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Contract Manufacturing Revenue in 2020
  • 3.5 Oral Solid Dosage Contract Manufacturing Key Players Head office and Area Served
  • 3.6 Key Players Oral Solid Dosage Contract Manufacturing Product Solution and Service
  • 3.7 Date of Enter into Oral Solid Dosage Contract Manufacturing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Solid Dosage Contract Manufacturing Breakdown Data by Type

  • 4.1 Global Oral Solid Dosage Contract Manufacturing Historic Market Size by Type (2016-2021)
  • 4.2 Global Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Type (2022-2027)

5 Oral Solid Dosage Contract Manufacturing Breakdown Data by Application

  • 5.1 Global Oral Solid Dosage Contract Manufacturing Historic Market Size by Application (2016-2021)
  • 5.2 Global Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Oral Solid Dosage Contract Manufacturing Market Size (2016-2027)
  • 6.2 North America Oral Solid Dosage Contract Manufacturing Market Size by Type
    • 6.2.1 North America Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2021)
    • 6.2.2 North America Oral Solid Dosage Contract Manufacturing Market Size by Type (2022-2027)
    • 6.2.3 North America Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2027)
  • 6.3 North America Oral Solid Dosage Contract Manufacturing Market Size by Application
    • 6.3.1 North America Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2021)
    • 6.3.2 North America Oral Solid Dosage Contract Manufacturing Market Size by Application (2022-2027)
    • 6.3.3 North America Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2027)
  • 6.4 North America Oral Solid Dosage Contract Manufacturing Market Size by Country
    • 6.4.1 North America Oral Solid Dosage Contract Manufacturing Market Size by Country (2016-2021)
    • 6.4.2 North America Oral Solid Dosage Contract Manufacturing Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Oral Solid Dosage Contract Manufacturing Market Size (2016-2027)
  • 7.2 Europe Oral Solid Dosage Contract Manufacturing Market Size by Type
    • 7.2.1 Europe Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2021)
    • 7.2.2 Europe Oral Solid Dosage Contract Manufacturing Market Size by Type (2022-2027)
    • 7.2.3 Europe Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2027)
  • 7.3 Europe Oral Solid Dosage Contract Manufacturing Market Size by Application
    • 7.3.1 Europe Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2021)
    • 7.3.2 Europe Oral Solid Dosage Contract Manufacturing Market Size by Application (2022-2027)
    • 7.3.3 Europe Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2027)
  • 7.4 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country
    • 7.4.1 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country (2016-2021)
    • 7.4.2 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size (2016-2027)
  • 8.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Type
    • 8.2.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Application
    • 8.3.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region
    • 8.4.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Oral Solid Dosage Contract Manufacturing Market Size (2016-2027)
  • 9.2 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Type
    • 9.2.1 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2021)
    • 9.2.2 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Type (2022-2027)
    • 9.2.3 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2027)
  • 9.3 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Application
    • 9.3.1 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2021)
    • 9.3.2 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Application (2022-2027)
    • 9.3.3 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2027)
  • 9.4 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Country
    • 9.4.1 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Country (2016-2021)
    • 9.4.2 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size (2016-2027)
  • 10.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Type
    • 10.2.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Application
    • 10.3.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country
    • 10.4.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Catalent
    • 11.1.1 Catalent Company Details
    • 11.1.2 Catalent Business Overview
    • 11.1.3 Catalent Oral Solid Dosage Contract Manufacturing Introduction
    • 11.1.4 Catalent Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.1.5 Catalent Recent Development
  • 11.2 DPx
    • 11.2.1 DPx Company Details
    • 11.2.2 DPx Business Overview
    • 11.2.3 DPx Oral Solid Dosage Contract Manufacturing Introduction
    • 11.2.4 DPx Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.2.5 DPx Recent Development
  • 11.3 Lonza Group (Capsugel)
    • 11.3.1 Lonza Group (Capsugel) Company Details
    • 11.3.2 Lonza Group (Capsugel) Business Overview
    • 11.3.3 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Introduction
    • 11.3.4 Lonza Group (Capsugel) Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.3.5 Lonza Group (Capsugel) Recent Development
  • 11.4 Piramal Pharma Solutions
    • 11.4.1 Piramal Pharma Solutions Company Details
    • 11.4.2 Piramal Pharma Solutions Business Overview
    • 11.4.3 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Introduction
    • 11.4.4 Piramal Pharma Solutions Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.4.5 Piramal Pharma Solutions Recent Development
  • 11.5 Aenova
    • 11.5.1 Aenova Company Details
    • 11.5.2 Aenova Business Overview
    • 11.5.3 Aenova Oral Solid Dosage Contract Manufacturing Introduction
    • 11.5.4 Aenova Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.5.5 Aenova Recent Development
  • 11.6 Jubilant
    • 11.6.1 Jubilant Company Details
    • 11.6.2 Jubilant Business Overview
    • 11.6.3 Jubilant Oral Solid Dosage Contract Manufacturing Introduction
    • 11.6.4 Jubilant Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.6.5 Jubilant Recent Development
  • 11.7 Famar
    • 11.7.1 Famar Company Details
    • 11.7.2 Famar Business Overview
    • 11.7.3 Famar Oral Solid Dosage Contract Manufacturing Introduction
    • 11.7.4 Famar Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.7.5 Famar Recent Development
  • 11.8 Boehringer Ingelheim
    • 11.8.1 Boehringer Ingelheim Company Details
    • 11.8.2 Boehringer Ingelheim Business Overview
    • 11.8.3 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Introduction
    • 11.8.4 Boehringer Ingelheim Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.8.5 Boehringer Ingelheim Recent Development
  • 11.9 Fareva Holding
    • 11.9.1 Fareva Holding Company Details
    • 11.9.2 Fareva Holding Business Overview
    • 11.9.3 Fareva Holding Oral Solid Dosage Contract Manufacturing Introduction
    • 11.9.4 Fareva Holding Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.9.5 Fareva Holding Recent Development
  • 11.10 AbbVie Contract Manufacturing
    • 11.10.1 AbbVie Contract Manufacturing Company Details
    • 11.10.2 AbbVie Contract Manufacturing Business Overview
    • 11.10.3 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Introduction
    • 11.10.4 AbbVie Contract Manufacturing Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.10.5 AbbVie Contract Manufacturing Recent Development
  • 11.11 Nipro Pharma
    • 11.11.1 Nipro Pharma Company Details
    • 11.11.2 Nipro Pharma Business Overview
    • 11.11.3 Nipro Pharma Oral Solid Dosage Contract Manufacturing Introduction
    • 11.11.4 Nipro Pharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.11.5 Nipro Pharma Recent Development
  • 11.12 Sopharma
    • 11.12.1 Sopharma Company Details
    • 11.12.2 Sopharma Business Overview
    • 11.12.3 Sopharma Oral Solid Dosage Contract Manufacturing Introduction
    • 11.12.4 Sopharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.12.5 Sopharma Recent Development
  • 11.13 Mylan (DPT Laboratories)
    • 11.13.1 Mylan (DPT Laboratories) Company Details
    • 11.13.2 Mylan (DPT Laboratories) Business Overview
    • 11.13.3 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Introduction
    • 11.13.4 Mylan (DPT Laboratories) Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.13.5 Mylan (DPT Laboratories) Recent Development
  • 11.14 Recipharm
    • 11.14.1 Recipharm Company Details
    • 11.14.2 Recipharm Business Overview
    • 11.14.3 Recipharm Oral Solid Dosage Contract Manufacturing Introduction
    • 11.14.4 Recipharm Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.14.5 Recipharm Recent Development
  • 11.15 NextPharma
    • 11.15.1 NextPharma Company Details
    • 11.15.2 NextPharma Business Overview
    • 11.15.3 NextPharma Oral Solid Dosage Contract Manufacturing Introduction
    • 11.15.4 NextPharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.15.5 NextPharma Recent Development
  • 11.16 Dishman
    • 11.16.1 Dishman Company Details
    • 11.16.2 Dishman Business Overview
    • 11.16.3 Dishman Oral Solid Dosage Contract Manufacturing Introduction
    • 11.16.4 Dishman Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.16.5 Dishman Recent Development
  • 11.17 Aesica Pharmaceuticals
    • 11.17.1 Aesica Pharmaceuticals Company Details
    • 11.17.2 Aesica Pharmaceuticals Business Overview
    • 11.17.3 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Introduction
    • 11.17.4 Aesica Pharmaceuticals Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.17.5 Aesica Pharmaceuticals Recent Development
  • 11.18 CordenPharma
    • 11.18.1 CordenPharma Company Details
    • 11.18.2 CordenPharma Business Overview
    • 11.18.3 CordenPharma Oral Solid Dosage Contract Manufacturing Introduction
    • 11.18.4 CordenPharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
    • 11.18.5 CordenPharma Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Oral Solid Dosage Contract Manufacturing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Solid Dosage Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Tablets
    Capsules
    Powders & Granules
    Others

    Segment by Application
    Specialty/Midsize
    Generics
    Big Pharma
    Other

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Catalent
    DPx
    Lonza Group (Capsugel)
    Piramal Pharma Solutions
    Aenova
    Jubilant
    Famar
    Boehringer Ingelheim
    Fareva Holding
    Piramal Pharma Solutions
    Aenova
    Sopharma
    Mylan (DPT Laboratories)
    Recipharm
    NextPharma
    Dishman
    Aesica Pharmaceuticals

    Buy now